Bristol-Myers Squibb to acquire Mirati in $5.8 billion deal

Indonesia Berita Berita

Bristol-Myers Squibb to acquire Mirati in $5.8 billion deal
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 97%

Bristol-Myers Squibb (BMY.N) on Sunday said it will acquire Mirati Therapeutics (MRTX.O) in a transaction that values the cancer drugmaker at up to $5.8 billion.

Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File PhotoMirati stockholders will receive one non-tradeable contingent value right for each Mirati share held, potentially worth $12.00 per share in cash, representing an additional $1 billion of value opportunity, the company added.

The transaction will help grow Bristol-Myers’s oncology franchise with the addition of Mirati's lung cancer drug Krazati. Bristol is buying Mirati at a time when the shares are considerably cheaper than they were. Mirati's shares touched a 52-week high of $101.3 apiece on Nov. 28 and are now trading at $60.2.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Bristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Baca lebih lajut »

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionBristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionDeal expands pharmaceutical company’s portfolio of cancer drugs
Baca lebih lajut »

Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionBristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionMirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its...
Baca lebih lajut »

Elyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulElyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulFrom adult diapers to a mini-fridge, Elyse Myers reveals the products she can't live without since giving birth to her second child.
Baca lebih lajut »

Lucrative Bristol Bay red king crab fishery to reopen after 2-year closureLucrative Bristol Bay red king crab fishery to reopen after 2-year closureThe Alaska Department of Fish and Game announced Friday morning that the lucrative crab fishery will open Oct. 15.
Baca lebih lajut »

Something went wrong. Please disable your blocker on Collider.Something went wrong. Please disable your blocker on Collider.Michael Myers and Pinhead could have teamed up to raise hell together!
Baca lebih lajut »



Render Time: 2025-02-27 21:51:17